Blocking the CD47-Sirpa Axis Enhances Tafasitamab-Mediated Phagocytosis

被引：2

作者：

Biedermann, Alexander ^{[1
]}

Mangelberger-Eberl, Doris ^{[2
]}

Mougiakakos, Dimitrios ^{[3
]}

Buettner-Herold, Maike ^{[4
]}

Flamann, Cindy ^{[5
]}

Kellner, Christian ^{[6
]}

Altmeyer, Sarah ^{[7
]}

Bittenbring, Joerg ^{[8
]}

Augsberger, Christian ^{[2
]}

Patra-Kneuer, Maria ^{[2
]}

Landgraf, Karin ^{[2
]}

Ilieva-Babinsky, Kristina ^{[2
]}

Haskamp, Stefan ^{[1
]}

Beier, Fabian ^{[9
]}

Voelkl, Simon ^{[10
]}

Pallasch, Christian ^{[11
]}

Jacobs, Benedikt ^{[12
]}

Steidl, Stefan ^{[2
]}

Heitmueller, Christina ^{[2
]}

Mackensen, Andreas ^{[10
]}

Bruns, Heiko ^{[10
]}

机构：

[1] Univ Hosp Erlangen, Erlangen, Germany

[2] MorphoSys AG, Planegg, Germany

[3] Otto von Guericke Univ, Magdeburg, Germany

[4] Friedrich Alexander Univ Erlangen Nurnberg, Dept Nephropathol, Erlangen, Germany

[5] Univ Erlangen Nurnberg, Dept Internal Med Hematol Oncol 5, Erlangen, Germany

[6] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Transfus Med Cell Therapeut & Hemostaseol, Munich, Germany

[7] Saarland Univ Hosp, Homburg, Germany

[8] Univ Saarland, Med Sch, Dept Hematol Oncol Clin Immunol Rheumatol, Homburg, Germany

[9] Rhein Westfal TH Aachen, Med Fac, Dept Hematol Oncol Hemostaseol & Stem Cell Transp, Aachen, Germany

[10] Univ Hosp Erlangen, Dept Internal Med Hematol Oncol 5, Erlangen, Germany

[11] Univ Hosp Cologne, Cologne, Germany

[12] Univ Hosp Erlangen, Dept Hematol & Oncol, Erlangen, Germany

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-159955

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：9292 / 9293

页数：2

共 50 条

[1] Blocking the CD47-SIRPα Axis enhances Tafasitamab-mediated phagocytosis
Biedermann, A.
Mangelberger-Eberl, D.
Mougiakakos, D.
Buettner-Herold, M.
Patra-Kneuer, M.
Flamann, C.
Kellner, C.
Peipp, M.
Altmeyer, S.
Bittenbring, J.
Augsberger, C.
Landgraf, K.
Ilieva-Babinsky, K.
Hasskamp, S.
Beier, F.
Lischer, C.
Vera, J.
Voelkl, S.
Jacobs, B.
Steidl, S.
Heitmueller, C.
Mackensen, A.
Bruns, H.
ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 269 - 269
[2] Blocking the CD47-SIRPa axis in non-alcoholic steatohepatitis enhances necroptotic hepatocyte uptake and improves hepatic fibrosis
Shi, Hongxue
Wang, Xiaobo
Gerlach, Brennan
Yurdagul, Arif
Cai, Bishuang
Zeldin, Sharon
Valenti, Luca
Tabas, Ira
JOURNAL OF HEPATOLOGY, 2021, 75 : S607 - S607
[3] A Perspective on the CD47-SIRPA Axis in High-Risk Neuroblastoma
Tang, Xao X.
Shimada, Hiroyuki
Ikegaki, Naohiko
CURRENT ONCOLOGY, 2024, 31 (06) : 3212 - 3226
[4] Targeting CD47-SIRPa axis for Hodgkin and non-Hodgkin lymphoma immunotherapy
Zhao, Pengcheng
Xie, Longyan
Yu, Lei
Wang, Ping
GENES & DISEASES, 2024, 11 (01) : 205 - 217
[5] BLOCKING "DON'T-EAT-ME" SIGNAL OF CD47-SIRPa BY ANTI-SIRPa ANTIBODY ENHANCES ANTI-TUMOR EFFICACY OF TRASTUZUMAB DERUXTECAN
Sue, Mayumi
Tsubaki, Takuya
Ishimoto, Yoko
Hayashi, Shinko
Ishida, Saori
Isumi, Yoshitaka
Ishiguro, Jun
Kawaida, Reimi
Ohtsuka, Toshiaki
Wada, Teiji
Agatsuma, Toshinori
Kawasaki, Norihito
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A844 - A844
[6] Improving antibody-based immunotherapy of multiple myeloma by blocking the "Don't Eat Me" signal (CD47-SIRPa axis)
Ahmed, M. S.
Gehlert, C. L.
Krohn, S.
Boje, A. S.
Lustig, M.
Valerius, T.
Besse, L.
Besse, A.
Driessen, C.
Gramatzki, M.
Kellner, C.
Peipp, M.
Klausz, K.
ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 86 - 87
[7] TARGETING CD47-SIRPA FOR THE CONTROLLING MALIGNANT EFFUSION IN PRIMARY EFFUSION LYMPHOMA
Goto, Hiroki
Kariya, Ryusho
Matsuda, Kouki
Kudo, Erika
Okada, Seiji
EXPERIMENTAL HEMATOLOGY, 2013, 41 (08) : S55 - S55
[8] Targeting CD47-SIRPa interaction by novel peptide-based antagonists
Sasikumar, Pottayil G.
Gundala, Chennakrishnareddy
Gowda, Nagaraj M.
Naremaddepalli, Sudarshan S.
Bhumireddy, Archana
Nair, Rashmi
Balasubramanian, Wesley Roy
Lakshminarasimhan, Anirudha
Dodheri, Samiulla S.
Aithal, Kiran
Ramachandra, Raghuveer K.
Daginakatte, Girish
Ramachandra, Murali
CANCER RESEARCH, 2017, 77
[9] Identification of a macrocyclic peptide that blocks the CD47-SIRPa interaction and its antitumor effect
Hazama, Daisuke
Murata, Yoji
Okamoto, Takeshi
Tanaka, Daisuke
Sakamoto, Mariko
Kakuchi, Yuka
Saito, Yasuyuki
Kotani, Takenori
Nishimura, Yoshihiro
Matozaki, Takashi
CANCER RESEARCH, 2020, 80 (16)
[10] Expression and Prognostic Significance of CD47-SIRPA Macrophage Checkpoint Molecules in Colorectal Cancer
Sugimura-Nagata, Akane
Koshino, Akira
Inoue, Satoshi
Matsuo-Nagano, Aya
Komura, Masayuki
Riku, Miho
Ito, Hideaki
Inoko, Akihito
Murakami, Hideki
Ebi, Masahide
Ogasawara, Naotaka
Tsuzuki, Toyonori
Takahashi, Satoru
Kasugai, Kunio
Kasai, Kenji
Inaguma, Shingo
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (05) : 1 - 12

← 1 2 3 4 5 →